Evaluating of Role of Myeloperoxidase in Prediction of Outcomes of Cardiac Surgery Procedures. (MPO-CSP)
Sponsor: St. Petersburg State Pavlov Medical University
Listed as NCT03786965, this NA trial focuses on Cardiac Procedure Complication and Defect Septal and remains ongoing. Sponsored by St. Petersburg State Pavlov Medical University, it has been updated 9 times since 2018, reflecting limited change activity. This study contributes longitudinal data to the cardiovascular research landscape.
Status Flow
Change History
9 versions recorded-
Jan 2026 — Present [monthly]
Unknown NA
Status: Recruiting → Unknown
-
Sep 2025 — Jan 2026 [monthly]
Recruiting NA
-
Sep 2024 — Sep 2025 [monthly]
Recruiting NA
-
Jul 2024 — Sep 2024 [monthly]
Recruiting NA
-
Dec 2021 — Jul 2024 [monthly]
Recruiting NA
▶ Show 4 earlier versions
-
Jan 2021 — Dec 2021 [monthly]
Recruiting NA
-
Aug 2020 — Jan 2021 [monthly]
Recruiting NA
-
Apr 2019 — Aug 2020 [monthly]
Recruiting NA
-
Jan 2019 — Apr 2019 [monthly]
Recruiting NA
First recorded
Dec 2018
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- St. Petersburg State Pavlov Medical University
For direct contact, visit the study record on ClinicalTrials.gov .